RUNX1 and colorectal carcinoma: Expanding on our previously published RNA-Seq findings that characterized the highly invasive phenotype of the F3-Caco-2 cell line 22, this study employed ChIP-Seq to identify direct transcriptional targets of RUNX1, aiming to further elucidate the genetic mechanisms underlying RUNX1's role in CRC aggressiveness.